ONCO Scorecard | Onconetix, Inc.

Onconetix, Inc. (ONCO) Scorecard

2026-Q2: Total return Lose; Revenue growth Lose; EPS growth Lose.
2026-Q1: Total return Lose; Revenue growth Lose; EPS growth Lose.
2025-Q4: Total return Lose; Revenue growth Lose; EPS growth Lose.
2025-Q3: Total return Lose; Revenue growth Lose; EPS growth Lose.

40 QUARTERS × 3 ROAST BATTLES

8/120 All 120 Win/Lose results shown below

Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.

Trailing 1 year (4 quarters): 0 wins, 12 lossesLast fetched: 4 Sept 2026

Complete point ledger

Each cell identifies the missing side explicitly.

Quarter	Total return	Revenue growth	EPS growth
2026-Q20/3	LoseONCO / S&P -92.42% / 15.20%	LoseONCO / S&P -51.33% / 15.00%	LoseONCO / S&P -100.30% / 50.40%
2026-Q10/3	LoseONCO / S&P -80.90% / -4.33%	LoseONCO / S&P -61.81% / 11.30%	LoseONCO / S&P -83.09% / 27.70%
2025-Q40/3	LoseONCO / S&P -49.84% / 2.65%	LoseONCO / S&P -67.70% / 9.00%	LoseONCO / S&P -61.83% / 13.40%
2025-Q30/3	LoseONCO / S&P -34.80% / 8.12%	LoseONCO / S&P ONCO unavailable / 4.61%	LoseONCO / S&P -131.35% / 13.45%
2025-Q20/3	LoseONCO / S&P -28.05% / 10.94%	LoseONCO / S&P ONCO unavailable / 4.83%	LoseONCO / S&P -123.94% / 10.63%
2025-Q11/3	LoseONCO / S&P -87.62% / -4.27%	LoseONCO / S&P ONCO unavailable / 4.98%	WinONCO / S&P 1586.44% / 10.57%
2024-Q41/3	LoseONCO / S&P -87.88% / 2.41%	LoseONCO / S&P ONCO unavailable / 5.25%	WinONCO / S&P 1788.19% / 6.15%
2024-Q31/3	LoseONCO / S&P -22.16% / 5.89%	LoseONCO / S&P ONCO unavailable / 5.89%	WinONCO / S&P 19249.69% / 6.11%
2024-Q22/3	WinONCO / S&P 8.44% / 4.28%	LoseONCO / S&P ONCO unavailable / 5.38%	WinONCO / S&P 218623.08% / 5.12%
2024-Q11/3	LoseONCO / S&P -22.22% / 10.56%	LoseONCO / S&P ONCO unavailable / 5.71%	WinONCO / S&P 8514.43% / 5.59%
2023-Q41/3	LoseONCO / S&P -61.33% / 11.69%	LoseONCO / S&P ONCO unavailable / 6.81%	WinONCO / S&P 5533.63% / 7.78%
2023-Q31/3	LoseONCO / S&P -54.69% / -3.27%	LoseONCO / S&P ONCO unavailable / 7.52%	WinONCO / S&P 833.81% / -5.03%
2023-Q20/3	LoseONCO / S&P 5.61% / 8.74%	LoseONCO / S&P ONCO unavailable / 9.50%	LoseONCO / S&P -31.58% / -8.57%
2023-Q10/3	LoseONCO / S&P -2.73% / 7.50%	LoseONCO / S&P ONCO unavailable / 10.77%	LoseONCO / S&P -33.10% / -15.69%
2022-Q40/3	LoseONCO / S&P -35.67% / 7.56%	LoseONCO / S&P ONCO unavailable / 11.88%	LoseONCO / S&P ONCO unavailable / -17.99%
2022-Q30/3	LoseONCO / S&P -19.72% / -4.88%	LoseONCO / S&P ONCO unavailable / 13.47%	LoseONCO / S&P ONCO unavailable / -1.41%
2022-Q20/3	LoseONCO / S&P -96.23% / -16.10%	LoseONCO / S&P ONCO unavailable / 13.71%	LoseONCO / S&P ONCO unavailable / 11.04%
2022-Q10/3	LoseONCO / S&P ONCO unavailable / -4.60%	LoseONCO / S&P ONCO unavailable / 15.97%	LoseONCO / S&P ONCO unavailable / 42.23%
2021-Q40/3	LoseONCO / S&P ONCO unavailable / 11.03%	LoseONCO / S&P ONCO unavailable / 15.00%	LoseONCO / S&P ONCO unavailable / 96.40%
2021-Q30/3	LoseONCO / S&P ONCO unavailable / 0.58%	LoseONCO / S&P ONCO unavailable / 10.77%	LoseONCO / S&P ONCO unavailable / 69.42%
2021-Q20/3	LoseONCO / S&P ONCO unavailable / 8.55%	LoseONCO / S&P ONCO unavailable / 6.58%	LoseONCO / S&P ONCO unavailable / 51.81%
2021-Q10/3	LoseONCO / S&P ONCO unavailable / 6.17%	LoseONCO / S&P ONCO unavailable / -1.06%	LoseONCO / S&P ONCO unavailable / 7.39%
2020-Q40/3	LoseONCO / S&P ONCO unavailable / 12.15%	LoseONCO / S&P ONCO unavailable / -3.72%	LoseONCO / S&P ONCO unavailable / -33.42%
2020-Q30/3	LoseONCO / S&P ONCO unavailable / 8.93%	LoseONCO / S&P ONCO unavailable / -2.04%	LoseONCO / S&P ONCO unavailable / -27.10%
2020-Q20/3	LoseONCO / S&P ONCO unavailable / 20.54%	LoseONCO / S&P ONCO unavailable / -0.46%	LoseONCO / S&P ONCO unavailable / -27.11%
2020-Q10/3	LoseONCO / S&P ONCO unavailable / -19.60%	LoseONCO / S&P ONCO unavailable / 3.47%	LoseONCO / S&P ONCO unavailable / -14.75%
2019-Q40/3	LoseONCO / S&P ONCO unavailable / 9.07%	LoseONCO / S&P ONCO unavailable / 5.36%	LoseONCO / S&P ONCO unavailable / 2.99%
2019-Q30/3	LoseONCO / S&P ONCO unavailable / 1.70%	LoseONCO / S&P ONCO unavailable / 5.02%	LoseONCO / S&P ONCO unavailable / 0.21%
2019-Q20/3	LoseONCO / S&P ONCO unavailable / 4.30%	LoseONCO / S&P ONCO unavailable / 6.64%	LoseONCO / S&P ONCO unavailable / 8.65%
2019-Q10/3	LoseONCO / S&P ONCO unavailable / 13.65%	LoseONCO / S&P ONCO unavailable / 8.12%	LoseONCO / S&P ONCO unavailable / 14.29%
2018-Q40/3	LoseONCO / S&P ONCO unavailable / -13.52%	LoseONCO / S&P ONCO unavailable / 9.05%	LoseONCO / S&P ONCO unavailable / 18.23%
2018-Q30/3	LoseONCO / S&P ONCO unavailable / 7.71%	LoseONCO / S&P ONCO unavailable / 10.21%	LoseONCO / S&P ONCO unavailable / 19.06%
2018-Q20/3	LoseONCO / S&P ONCO unavailable / 3.43%	LoseONCO / S&P ONCO unavailable / 9.03%	LoseONCO / S&P ONCO unavailable / 14.46%
2018-Q10/3	LoseONCO / S&P ONCO unavailable / -0.76%	LoseONCO / S&P ONCO unavailable / 7.68%	LoseONCO / S&P ONCO unavailable / 12.46%
2017-Q40/3	LoseONCO / S&P ONCO unavailable / 6.64%	LoseONCO / S&P ONCO unavailable / 7.03%	LoseONCO / S&P ONCO unavailable / 13.82%
2017-Q30/3	LoseONCO / S&P ONCO unavailable / 4.48%	LoseONCO / S&P ONCO unavailable / 5.68%	LoseONCO / S&P ONCO unavailable / 17.57%
2017-Q20/3	LoseONCO / S&P ONCO unavailable / 3.09%	LoseONCO / S&P ONCO unavailable / 4.83%	LoseONCO / S&P ONCO unavailable / 17.74%
2017-Q10/3	LoseONCO / S&P ONCO unavailable / 6.07%	LoseONCO / S&P ONCO unavailable / 3.67%	LoseONCO / S&P ONCO unavailable / 13.32%
2016-Q40/3	LoseONCO / S&P ONCO unavailable / 3.82%	LoseONCO / S&P ONCO unavailable / 2.09%	LoseONCO / S&P ONCO unavailable / 7.05%
2016-Q30/3	LoseONCO / S&P ONCO unavailable / 3.85%	LoseONCO / S&P ONCO unavailable / 0.20%	LoseONCO / S&P ONCO unavailable / -3.15%

Dividend-reinvested, split-adjusted total return

1Y · 2025-08-29 to 2026-08-27

Metric	ONCO total return	S&P 500 Total Return Index
Total return	-99.57%	20.78%
Annualized return	-99.57%	20.78%

5Y · 2022-02-18 to 2026-08-27

Metric	ONCO total return	S&P 500 Total Return Index
Total return	-100.00%	83.14%
Annualized return	-96.35%	12.86%

10Y · 2022-02-18 to 2026-08-27

Metric	ONCO total return	S&P 500 Total Return Index
Total return	-100.00%	319.30%
Annualized return	-80.90%	15.41%

Calculation rules

window: Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
return Basis: Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
point Rule: Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
frequency: Quarter endpoints only.
fundamentals: Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
non Scoring

Snapshot captured 2026-09-04.

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
HCW Biologics Inc. (HCWB)	United States	$0.004B	-6.15
REVELATION BIOSCIENCES, INC. (REVB)	United States	$0.004B
Aptevo Therapeutics Inc. (APVO)	United States	$0.003B
Sunshine Biopharma Inc. (SBFM)		$0.003B
60 DEGREES PHARMACEUTICALS, INC. (SXTP)	United States	$0.004B	-0.59
Alaunos Therapeutics, Inc. (TCRT)	United States	$0.003B	-1.44
Genprex, Inc. (GNPX)	United States	$0.003B	-0.02
Silo Pharma, Inc. (SILO)	United States	$0.003B	-1.57
Lakewood-Amedex Biotherapeutics Inc. (LABT)	United States	$0.004B
Cadrenal Therapeutics, Inc. (CVKD)	United States	$0.004B	-0.90